The approval is for the 1.2ml and 2.4ml prefilled pen injections that reference AstraZeneca’s Byetta. "Amneal files again for FDA approval of first dihydroergotamine autoinjector" was originally ...
The new authorisation has been granted for a single-dose, pre-filled pen device that requires no ... and AZ'[s twice-daily exenatide formulation, Byetta. After 28 weeks of treatment, patients ...
Amneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the GLP-1 agonist diabetes drug Byetta and resubmitted its New Drug Application for a prefilled syringe ...